SCHEMBL471860

SCHEMBL471860

O=c1c(O)c(-c2cccc(O)c2O)oc2ccccc12

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NMUR2 Q9GZQ4 4/20 0.68
KDM4E B2RXH2 10/20 0.64
MEN1 O00255 9/20 0.64
KMT2A Q03164 9/20 0.64
CYP3A4 P08684 9/20 0.64
ALOX15 P16050 6/20 0.64
TP53 P04637 6/20 0.64
MAPK1 P28482 6/20 0.64
LMNA P02545 3/20 0.64
CA12 O43570 1/20 0.64
CA1 P00915 1/20 0.64
CA2 P00918 1/20 0.64
ABCB1 P08183 1/20 0.64
CALM1 P0DP23 1/20 0.64
AR P10275 1/20 0.64
PKM P14618 1/20 0.64
CYP1B1 Q16678 1/20 0.64
CA9 Q16790 1/20 0.64
HSD17B10 Q99714 7/20 0.62
HPGD P15428 6/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL290080 0.90 NMUR2 (0.71) NMUR2KDM4EMEN1KMT2ACYP3A4
SCHEMBL31675811 0.90 NMUR2 (0.71) NMUR2KDM4EMEN1KMT2ACYP3A4
SCHEMBL157971 0.87 KDM4E (0.64) NMUR2KDM4EMEN1KMT2ACYP3A4
SCHEMBL773152 0.84 NMUR2 (0.68) NMUR2KDM4EMEN1KMT2ACYP3A4
SCHEMBL3062193 0.83 KDM4E (0.72) NMUR2KDM4EMEN1KMT2ACYP3A4
SCHEMBL505415 0.83 DHFR (0.68) NMUR2KDM4EMEN1KMT2ACYP3A4
SCHEMBL1255489 0.81 CYP3A4 (0.57) NMUR2KDM4EMEN1KMT2ACYP3A4
SCHEMBL9665953 0.81 KDM4E (0.84) NMUR2KDM4EMEN1KMT2ACYP3A4
SCHEMBL15676117 0.81 NMUR2 (0.68) NMUR2KDM4EMEN1KMT2ACYP3A4
SCHEMBL16586869 0.81 NMUR2 (0.68) NMUR2KDM4EMEN1KMT2ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 618 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117695202-B Probiotic metazoan composition for improving scalp environment and preparation method and application thereof 金华银河生物科技有限公司 2025-05-02 CN claimed
WO-2025038971-A1 OLIGONUCLEOTIDES CONTAINING A LIGAND AT A NUCLEOBASE, 2' POSITION, OR 3' POSITION ADARX PHARMACEUTICALS, INC. (US) 2025-02-20 WO claimed
CN-118557502-A Water supplementing and moisturizing probiotic metazoan composition and application thereof 北京科拓恒通生物技术股份有限公司 2024-08-30 CN claimed
CN-117695202-A Probiotic metazoan composition for improving scalp environment and preparation method and application thereof 金华银河生物科技有限公司 2024-03-15 CN claimed
CN-117678473-A Arbuscular mycorrhizal fungus agent and preparation method thereof 广东中微环保生物科技有限公司 2024-03-12 CN claimed
WO-2023154896-A2 TRKB LIGAND CONJUGATED COMPOUNDS AND USES THEREOF ADARX PHARMACEUTICALS, INC. (US) 2023-08-17 WO claimed
US-20230248755-A1 COMPOSITIONS FOR IMPROVING JOINT HEALTH BioRelief, LLC (US) 2023-08-10 US claimed
CN-115429821-A Compound probiotic composition for preventing dental caries and regulating intestinal flora and immunity and preparation method and application thereof 北京科拓恒通生物技术股份有限公司 2022-12-06 CN claimed
CN-114796188-A Plant-derived flavone antibacterial compound and application thereof 朱奎 2022-07-29 CN claimed
CN-112999143-B Repairing and relieving skin care product containing metazoan components and preparation method thereof 山东艾益典生物技术有限公司 2022-06-24 CN claimed
US-20070037193-A1 Modulation of peroxisome proliferator-activated receptors ABGENOMICS CORPORATION (TW) 2007-02-15 US claimed
US-20060135585-A1 Compounds and methods for thiol-containing compound efflux and cancer treatment NATIONAL JEWISH MEDICAL AND RESEARCH CENTER (US) 2006-06-22 US claimed
CN-1681470-A Agent for dyeing keratinous fibres HENKEL KGAA (DE) 2005-10-12 CN claimed
EP-1542871-A1 METHOD FOR MAKING PRINTING PLATE BY INKJET DEPOSITION ON POSITIVE-WORKING MEDIA Creo SRL (CA) 2005-06-22 EP claimed
CN-1592628-A Compositions and methods for treating diabetes ZIEGLER RANDY H (US) 2005-03-09 CN claimed
CN-1517086-A Medical use of poly hydroxy flavone derivatives 上海凯曼生物科技有限公司 2004-08-04 CN claimed
US-20040038152-A1 Method for making printing plate by inkjet deposition on positive-working media CREO SRL (CA) 2004-02-26 US claimed
WO-2004007200-A1 METHOD FOR MAKING PRINTING PLATE BY INKJET DEPOSITION ON POSITIVE-WORKING MEDIA CREO SRL (CA) 2004-01-22 WO claimed
CN-1081455-C Hair dyeing agent with sorghum red as dyestuff ZHANG XUESONG (CN) 2002-03-27 CN claimed
CN-1274354-A Robustaflavone, intermediates and analogues and method for prepn. method MEDICHEM RES INC (US) 2000-11-22 CN claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060135585-A1 Compounds and methods for thiol-containing compound efflux and cancer treatment ABCC1, ABCC2, ABCB1 NMUR2 1775/4885KDM4E 4671/4885MEN1 4218/4885
US-20070037193-A1 Modulation of peroxisome proliferator-activated receptors PPARG, PPARA, PPARD NMUR2 1974/4885KDM4E 2891/4885MEN1 4798/4885
US-20230248755-A1 COMPOSITIONS FOR IMPROVING JOINT HEALTH TRPV1, CALCB, TRPV2 NMUR2 328/4885KDM4E 3932/4885MEN1 2869/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.